4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-24-039617
Chief Operating Officer sold 24,662 shares at $77.24 ($1,904,942)
- Chief Operating Officer acquired 24,662 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jacobson Mark L. Chief Operating Officer | 2024-04-01 | Option exercise 10b5-1 | +24,662 | $1.30 | $32,061 | 24,662 | D |
| Jacobson Mark L. Chief Operating Officer | 2024-04-01 | Sale 10b5-1 | −24,662 | $77.24 | $1,904,942 | 0 | D |
| Derivatives | |||||||
| Jacobson Mark L. Chief Operating Officer | 2024-04-01 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,662 | 0 | D | ||
| Open-market sales · 24,662 sh · avg $77.24 · $1,904,942 | |||||||
Loading xslF345X05/ownership.xml…